BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4249733)

  • 1. Chlorpromazine in chronic schizophrenia: behavioral dose-response relationships.
    Clark ML; Ramsey HR; Ragland RE; Rahhal DK; Serafetinides EA; Costiloe JP
    Psychopharmacologia; 1970; 18(3):260-70. PubMed ID: 4249733
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 3. Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health--psychopharmacology research branch collaborative study group.
    Arch Gen Psychiatry; 1968 Apr; 18(4):482-95. PubMed ID: 4868797
    [No Abstract]   [Full Text] [Related]  

  • 4. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
    Serafetinides EA; Collins S; Clark ML
    J Nerv Ment Dis; 1972 Jan; 154(1):31-42. PubMed ID: 4550211
    [No Abstract]   [Full Text] [Related]  

  • 5. High dose trifluoperazine therapy in chronic schizophrenia.
    Prien RF; Levine J; Cole JO
    Am J Psychiatry; 1969 Sep; 126(3):305-13. PubMed ID: 4895559
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioequivalency of generic and brand-named chlorpromazine.
    Simpson GM; Varga E; Reiss M; Cooper TB; Bergner PE; Lee JH
    Clin Pharmacol Ther; 1974 Jun; 15(6):631-41. PubMed ID: 4210298
    [No Abstract]   [Full Text] [Related]  

  • 7. Chlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships.
    Clark ML; Ramsey HR; Rahhal DK; Serafetinides EA; Wood FD; Costiloe JP
    Arch Gen Psychiatry; 1972 Oct; 27(4):479-83. PubMed ID: 5072717
    [No Abstract]   [Full Text] [Related]  

  • 8. Pimozide in chronic schizophrenic patients.
    Huber W; Serafetinides EA; Colmore JP; Clark M
    J Clin Pharmacol New Drugs; 1971; 11(4):304-9. PubMed ID: 4932748
    [No Abstract]   [Full Text] [Related]  

  • 9. Indications for high dose chlorpromazine therapy in chronic schizophrenia.
    Prien RF; Levine J; Cole JO
    Dis Nerv Syst; 1970 Nov; 31(11):739-45. PubMed ID: 4923151
    [No Abstract]   [Full Text] [Related]  

  • 10. The evaluation of chlorpromazine therapy in chronic schizophrenic women. A replicated experiment.
    Ragland R; Clark ML; Ray TS; Paredes A; Costiloe JP; Segal B; Wolf S
    J Chronic Dis; 1968 Oct; 21(6):445-60. PubMed ID: 4879902
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.
    Altman H; Mehta D; Evenson RC; Sletten IW
    J Am Geriatr Soc; 1973 Jun; 21(6):241-8. PubMed ID: 4575803
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.
    Matz R; Rick W; Thompson H; Gershon S
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):687-95. PubMed ID: 4210458
    [No Abstract]   [Full Text] [Related]  

  • 14. The place of thiothixene in the treatment of schizophrenic patients. A systematic clinical study.
    Sterlin C; Ban TA; Lehmann HE; Saxena BM
    Can Psychiatr Assoc J; 1970 Feb; 15(1):3-14. PubMed ID: 4906140
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled comparison of metiapine and chlorpromazine in chronic schizophrenia.
    Simpson GM; Haher EJ; Herkert E; Lee JH
    J Clin Pharmacol; 1973 Oct; 13(10):408-15. PubMed ID: 4583571
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled trial of combined medications on behavioral and extrapyramidal effects.
    Simpson GM; Krakov L; Kunz-Bartholini E
    Acta Psychiatr Scand Suppl; 1970; 212():20-7. PubMed ID: 4917968
    [No Abstract]   [Full Text] [Related]  

  • 17. Loxapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients.
    Steinbook RM; Goldstein BJ; Brauzer B; Moreno SS; Jacobson AF
    Curr Ther Res Clin Exp; 1973 Jan; 15(1):1-7. PubMed ID: 4631378
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
    Shopsin B; Pearson E; Gershon S; Collins P
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
    Kolivakis T; Azim H; Kingstone E
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.